# ZOKINVY
> **NDA213969** · New Drug Application · Sponsor: SENTYNL THERAPS INC · Approved 2020-11-20
## Drug
- **FDA Application Number:** NDA213969
- **Application type:** New Drug Application
- **Brand name:** ZOKINVY
- **Generic name:** LONAFARNIB
- **Active ingredients:** LONAFARNIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SENTYNL THERAPS INC
- **Manufacturer:** Sentynl Therapeutics, Inc.
- **First approval:** 2020-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213969)
---
*AI Analytics · CC0 1.0*